Drawing for Q QUANTUM RESEARCH FERRARIS CARDIORESPIRATORY

USPTO serial 78219788

Q QUANTUM RESEARCH FERRARIS CARDIORESPIRATORY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
VOGLER, ANN LINNEHAN
Law office
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Q QUANTUM RESEARCH FERRARIS CARDIORESPIRATORY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Broitman

JOSHUA S BROITMAN OSTRAGER CHONG & FLAHERTY LLP825 THIRD AVE 30TH FLNEW YORK NY, 10022 7519U.S. ARMY

Goods and services

ClassDescriptionStatusFirst use
010Cardiological apparatus and instruments, namely, holter recording devices, EGG recorders, ambulatory blood pressure monitors, event recorders, EGG hook up kits; apparatus and instruments for use in connection with respiratory conditions, namely, spirometers, electric peak flow meters, FEV meters, dosimeter, combination spirometer and personal diaries, aerosolizers, and lung analyzers; hypertension monitoring apparatus and instruments, namely, ambulatory blood pressure monitors; medical equipment accessories, namely, syringes, mouthpieces for spirometers, nose clips for pulmonary function tests; and structural parts for all the aforesaid goodsACTIVE—
035Computerized data management services; namely, management of clinical trials data, cardiological data, and respiratory data; data reporting services of clinical trials data, cardiological data and respiratory dataACTIVE—
037Rental of data processing equipment for use in clinical trials, namely, computers, computer software used for medical diagnostic tests, and equipment used for transmission or reproducing or receiving of sound, images, video or data over a telecommunications network or system between terminalsACTIVE—
042Medical and scientific research, namely, conducting clinical trials; clinical trials support services, namely, monitoring, reviewing and auditing clinical trial data; designing, monitoring, reviewing and auditing standard operating procedures and protocols for diagnostic and monitoring procedures relating to cardiology, respiratory, hypertension or ambulatory blood pressure; providing clinical trial quality control; medical consultation, namely, providing advice related to cardio-pulmonary monitoring and reporting and providing on-site clinical or workshop training related to cardio or respiratory diagnostic and monitoring techniquesACTIVE—
044Rental and leasing of medical equipment for use in clinical trials in relation to cardiological or respiratory conditions, namely, rental of holter recording devices, ECG recorders, ambulatory blood pressure monitors, event recorders, spirometers, electric peak flow meters, FEV meters, dosimeter, combination spirometers and personal diaries, aerosolizers, lung analyzers, syringes, mouthpieces for spirometers, nose clips for pulmonary function tests; medical services, namely, diagnostic services relating to cardiac and cardiological conditions, and rental and leasing of structural parts for all the aforesaid goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 29, 2004MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 29, 2004ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 23, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 19, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2004MAILPAPER RECEIVED—
Aug 18, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance